Codes / ICD10CM / H40.1432

H40.1432 Capsular glaucoma with pseudoexfoliation of lens, bilateral, moderate stage

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Capsular glaucoma with pseudoexfoliation of lens, bilateral, moderate stage (ICD-10: H40.1432)

Summary

Capsular glaucoma with pseudoexfoliation of lens, bilateral, moderate stage, is a type of secondary open-angle glaucoma affecting both eyes. It involves the accumulation of pseudoexfoliative material on the lens and ocular structures, which obstructs fluid drainage and increases intraocular pressure. This can lead to optic nerve damage and vision loss if untreated. The "moderate stage" designation indicates intermediate disease progression.

Causes

This condition is primarily caused by the deposition of pseudoexfoliative material, a fibrous substance that accumulates in the eye. The material disrupts the normal drainage of aqueous humor, resulting in elevated intraocular pressure and subsequent optic nerve damage.

Risk Factors

  • Age (more common in individuals over 60)
  • Genetic predisposition
  • Scandinavian or Mediterranean descent
  • Exposure to ultraviolet (UV) rays

Symptoms

  • Slowly progressing vision loss
  • Elevated eye pressure
  • Haloes around lights or eye discomfort (less common)

Diagnosis

Diagnosis involves a comprehensive eye examination by an ophthalmologist, including tonometry to measure intraocular pressure, gonioscopy to evaluate drainage angles, and imaging (e.g., optical coherence tomography) or visual field tests to assess optic nerve damage. The presence of pseudoexfoliative material on the lens is a key diagnostic indicator.

Treatment Options

  • Medications (e.g., eye drops to lower intraocular pressure)
  • Laser therapy (e.g., selective laser trabeculoplasty)
  • Surgical interventions (e.g., trabeculectomy or minimally invasive glaucoma surgery)

Prognosis and Follow-Up

With appropriate treatment, progression of optic nerve damage and vision loss can be slowed. Regular follow-up appointments are essential to monitor intraocular pressure, optic nerve health, and treatment efficacy. Adherence to prescribed therapies and lifestyle modifications supports long-term outcomes.

Complications

  • Progressive vision loss or blindness
  • Optic nerve damage
  • Increased risk of acute angle-closure glaucoma (rare)

Lifestyle & Prevention

  • Protect eyes from excessive UV exposure
  • Maintain regular eye examinations, especially for those with risk factors
  • Follow prescribed treatment regimens consistently

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden vision changes, severe eye pain, or haloes around lights, as these may indicate acute complications.

Tips for Medical Coders

Document the bilateral nature of the condition and the moderate stage of progression. Ensure clinical notes support the presence of pseudoexfoliative material and confirm the stage classification to justify code assignment.

Book a walkthrough

H40.1432 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.